Biocept Inc (NASDAQ: BIOC) Q4 2020 earnings call dated Mar. 29, 2021.
Corporate Participants:
Jody Cain — Investor Relations
Michael W. Nall — President and Chief Executive Officer
Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations
Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director
Analysts:
Michael Okunewitch — Maxim Group — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
SBUX Earnings: Key quarterly highlights from Starbucks’ Q4 2024 financial results
Starbucks Corporation (NASDAQ: SBUX) reported its fourth quarter 2024 earnings results today. Consolidated net revenues declined 3%, including on a constant currency basis, to $9.1 billion compared to the same
Key highlights from Biogen’s (BIIB) Q3 2024 earnings results
Biogen Inc. (NASDAQ: BIIB) reported its third quarter 2024 earnings results today. Total revenue decreased 3% year-over-year to $2.46 billion. Revenues were down 3% on a constant currency basis as
Infographic: Caterpillar (CAT) reports lower Q3 revenue and adj. profit
Caterpillar Inc. (NYSE: CAT), a leading manufacturer of construction and mining equipment, on Wednesday reported a decrease in revenue and adjusted earnings for the third quarter of 2024. Sales and